- Appearance
- Zone of opacity with clear cortex; 'riders'
- Visual Significance
- Variable — depends on density
- Inheritance / Association
- AD (most common hereditary type)
- Surgery Needed?
- If dense / central
Congenital cataract
Key Points
- •Leucocoria = retinoblastoma until proven otherwise — always rule out retinoblastoma before diagnosing congenital cataract.
- •Lamellar (zonular) cataract is the most common morphological type; often autosomal dominant inheritance.
- •Timing of surgery is critical: unilateral dense cataract by 4–6 weeks, bilateral by 6–8 weeks, to prevent irreversible deprivation amblyopia.
- •The IATS showed no visual acuity difference between primary IOL and contact lens at 4.5 years, but the IOL group had more adverse events and additional surgeries (Lambert et al. 2014).
- •An oil-droplet cataract in an infant is pathognomonic of galactosemia — check urine reducing substances and GALT assay immediately.
- •Glaucoma is the most significant long-term complication after paediatric cataract surgery (10–25% over 10 years).
Congenital cataract is a lens opacity present at birth or developing within the first year of life, representing the most common treatable cause of childhood blindness. It may be unilateral or bilateral and can occur in isolation or as part of a systemic syndrome. Early detection and intervention are critical to prevent stimulus deprivation amblyopia.
Prevalence: 1–6 per 10,000 live births in developed countries; up to 15 per 10,000 globally (range 1–15 per 10,000; higher in lower-resource settings) (WHO/IAPB). Responsible for 5–20% of childhood blindness worldwide. Bilateral cataracts are slightly more common than unilateral (~54% vs 46%; varies by aetiology — hereditary cataracts are predominantly bilateral, idiopathic more often unilateral). Approximately one-third are hereditary, one-third associated with systemic conditions, and one-third idiopathic. Autosomal dominant inheritance is the most common hereditary pattern. Incidence is higher in consanguineous populations. Lamellar (zonular) cataract is the most common morphological type overall (Kanski 9th Ed).
Hereditary (most common identifiable cause):
- Autosomal dominant (most frequent): mutations in crystallin genes (CRYAA, CRYAB, CRYBB2, CRYGC, CRYGD), connexin genes (GJA3, GJA8), MIP (aquaporin-0), and BFSP2
- Autosomal recessive and X-linked forms less common
Intrauterine infections (TORCH):
- Rubella (most common infectious cause): bilateral, pearly-white nuclear opacity; may contain live virus for up to 3 years
- Toxoplasmosis, CMV, herpes simplex, varicella, syphilis
Metabolic:
- Galactosemia (classic and Duarte variant): oil-droplet cataract; galactitol accumulation via polyol pathway
- Galactokinase deficiency: zonular/lamellar cataract
- Lowe syndrome (oculocerebrorenal): dense bilateral cataracts, X-linked recessive
- Hypoparathyroidism / hypocalcemia: lamellar cataract
- Maternal diabetes mellitus
- Mannosidosis, Fabry disease
Chromosomal:
- Trisomy 21 (Down syndrome): congenital cataract in ~1.4%; overall childhood cataract prevalence 5–15% (includes acquired forms)
- Trisomy 13 (Patau), Trisomy 18 (Edwards)
- Turner syndrome (45,X)
Syndromic:
- Hallermann-Streiff, Nance-Horan, Cockayne syndrome, myotonic dystrophy (Christmas-tree cataract in adults)
Idiopathic: ~30% of cases
- Disruption of lens fibre development: The lens develops from surface ectoderm. Primary lens fibres form the embryonic nucleus (by 8 weeks), and secondary fibres form the fetal nucleus (8 weeks to birth). Any insult during these critical periods causes opacity in the corresponding zone.
- Timing determines morphology: Insults during the first 3 weeks of lens development cause total cataract; insults at weeks 3–8 cause embryonic nuclear opacity; later insults cause fetal nuclear, lamellar, or cortical opacities.
- Rubella virus: Directly invades lens vesicle cells and persists, causing necrosis of lens fibres and chronic inflammation. Virus may remain viable in the lens for up to 3 years after birth — surgical specimens must be handled with caution.
- Metabolic cataracts: Accumulation of toxic metabolites (galactitol in galactosemia, sorbitol in diabetes) causes osmotic swelling of lens fibres via the polyol pathway, leading to fibre disruption.
- Genetic mutations: Crystallin gene mutations cause protein misfolding and aggregation; connexin mutations impair gap junctions between lens fibres, disrupting ion and metabolite transport.
Morphological classification (Taylor & Hoyt 6th Ed):
- Polar cataracts:
- Anterior polar: Small, well-circumscribed opacity on anterior capsule; usually bilateral, often visually insignificant. May be associated with anterior lenticonus or persistent pupillary membrane.
- Posterior polar: Opacity at posterior pole; may be associated with persistent hyaloid artery remnant or posterior lenticonus. Higher risk of PCR during surgery (opacity adherent to capsule).
- Nuclear cataract: Central opacity involving embryonic and/or fetal nucleus. Dense central opacities are visually significant.
- Lamellar (zonular) cataract: Most common morphological type. Opacity of a specific layer/zone of the lens with clear cortex outside. "Riders" (cortical projections) may be present. Often hereditary (AD).
- Total (complete) cataract: Entire lens opaque; white reflex (leucocoria).
- Sutural cataract: Opacity along the Y-sutures. Usually visually insignificant.
- Blue-dot (cerulean) cataract: Small blue-white punctate opacities in cortex and nucleus. AD inheritance, usually non-progressive.
- Membranous cataract: Spontaneous absorption of lens matter, leaving fused anterior and posterior capsules.
- Oil-droplet cataract: Central refractile opacity; pathognomonic of galactosemia.
Etiological classification: Hereditary, metabolic, TORCH-related, syndromic, idiopathic.
- Family history of congenital/childhood cataract (strongest risk factor for hereditary forms)
- Consanguinity (increases risk of autosomal recessive forms)
- Maternal TORCH infections, especially rubella in first trimester
- Maternal diabetes mellitus
- Maternal drug use: corticosteroids, tetracycline, thalidomide
- Maternal radiation exposure
- Low birth weight and prematurity
- Chromosomal abnormalities (Trisomy 21, 13, 18)
- Metabolic disorders: galactosemia, Lowe syndrome, hypoparathyroidism
- Systemic syndromes: Hallermann-Streiff, Nance-Horan, Cockayne, myotonic dystrophy
- Associated ocular anomalies: microphthalmos, persistent fetal vasculature (PFV), aniridia
Symptoms / Presentation:
- Leucocoria (white pupillary reflex): most common presenting sign
- Absent or poor red reflex on Bruckner test
- Strabismus (sensory esotropia/exotropia due to visual deprivation)
- Nystagmus (indicates dense bilateral cataracts with profound visual deprivation, typically if present before 2–3 months)
- Poor visual behaviour: lack of fixation, tracking, or response to visual stimuli
- Parents may notice white spot in the pupil
Signs:
- Variable lens opacity patterns (see classification)
- Microcornea / microphthalmos may be associated
- Persistent pupillary membrane remnants
- Posterior lenticonus (associated with posterior polar cataract)
- Persistent fetal vasculature (PFV): retrolental fibrovascular membrane, elongated ciliary processes
Systemic associations to evaluate:
- Rubella: deafness, cardiac defects (PDA), salt-and-pepper retinopathy
- Down syndrome: Brushfield spots, epicanthal folds, cardiac defects
- Lowe syndrome: intellectual disability, renal Fanconi syndrome, hypotonia (X-linked recessive males)
- Galactosemia: hepatomegaly, jaundice, failure to thrive, E. coli sepsis in neonates
- Marfan / homocystinuria: lens subluxation (differential, not true cataract)
Ocular assessment:
- Red reflex test (Bruckner test): Screening at birth and well-baby visits — most important screening tool
- Slit-lamp biomicroscopy: Morphological characterisation of opacity
- Dilated fundus examination: Rule out retinoblastoma, PFV, retinal pathology
- B-scan ultrasonography: If fundus not visible; rule out retinoblastoma (calcification), PFV
- Retinoscopy and cycloplegic refraction
- Keratometry and axial length (for IOL calculation if surgery planned)
- Visual assessment: preferential looking (Teller acuity cards), fixation pattern, CSM (central, steady, maintained)
Systemic workup (especially for bilateral cataracts):
- TORCH screen: Rubella IgM/IgG, Toxoplasma, CMV, HSV serologies
- Urine reducing substances (galactosemia): performed on non-glucose-specific test; GALT assay (galactose-1-phosphate uridyltransferase)
- Serum calcium, phosphorus, and PTH (hypoparathyroidism)
- Urine amino acids (Lowe syndrome: generalised aminoaciduria)
- Karyotype: if dysmorphic features or developmental delay (Trisomy 21, 13, 18)
- Blood glucose (maternal/neonatal diabetes)
- Genetic testing / whole exome sequencing: when hereditary cause suspected
- Retinoblastoma: Most critical differential for leucocoria. B-scan shows calcification. Urgent ophthalmology referral required. "Leucocoria = retinoblastoma until proven otherwise."
- Persistent fetal vasculature (PFV): Unilateral microphthalmos, retrolental fibrovascular mass, elongated ciliary processes. Typically unilateral.
- Retinopathy of prematurity (ROP): History of prematurity and oxygen therapy. Retinal findings on fundoscopy.
- Coats disease: Unilateral exudative retinal detachment with telangiectatic vessels. Older children (typically boys).
- Toxocariasis: Unilateral peripheral granuloma or endophthalmitis. Positive Toxocara serology.
- Norrie disease: X-linked recessive bilateral retinal dysplasia with leucocoria. Progressive deafness and intellectual disability.
Of the disease (untreated):
- Stimulus deprivation amblyopia: Most critical concern. Dense unilateral cataract untreated beyond 6–8 weeks causes irreversible amblyopia. Bilateral cataracts have a slightly longer window but still require urgent intervention.
- Sensory nystagmus: Develops if dense bilateral cataracts present before 2–3 months
- Strabismus
- Irreversible visual loss
Of surgery:
- Visual axis opacification (VAO) / secondary membrane: Very common in children (~40–100% without primary posterior capsulotomy). Managed by primary posterior capsulorhexis + anterior vitrectomy at time of surgery.
- Glaucoma: Most significant long-term complication; incidence 10–25% over 10 years. Higher risk with surgery in first year of life, microphthalmos.
- Posterior synechiae and chronic inflammation (more vigorous inflammatory response in children)
- Retinal detachment: Long-term risk ~1–3%
- Endophthalmitis: rare but devastating
- IOL decentration / capture
- Myopic shift: Significant as eye grows — requires frequent refraction updates
- Amblyopia persistence despite surgery if intervention delayed
Timing (critical):
- Unilateral dense cataract: Surgery by 4–6 weeks of age to prevent irreversible amblyopia
- Bilateral dense cataracts: Surgery by 6–8 weeks; second eye within 1–2 weeks of first
- Partial / lamellar cataracts: May be observed if visual axis clear and vision adequate
Surgical technique (Taylor & Hoyt 6th Ed):
- Lens aspiration (preferred in children): Anterior capsulorhexis, aspiration of soft lens material
- Primary posterior capsulorhexis + anterior vitrectomy: Essential in children < 5–7 years to prevent visual axis opacification
- IOL implantation: Controversial in infants < 6–12 months (Infant Aphakia Treatment Study — IATS, Lambert et al. 2014). Generally avoided < 6 months; primary IOL from 1–2 years onwards.
- IOL type: Single-piece acrylic foldable IOL in the bag. AcrySof (Alcon) commonly used.
- IOL power: Under-correction to account for myopic shift with eye growth — target hyperopia per Enyedi Rule of 7 (age + target = 7): +6 D at age 1, +5 D at age 2, +4 D at age 3, +3 D at age 4, +2 D at age 5, +1 D at age 6, plano at age 7.
Optical rehabilitation:
- Aphakic correction (if no IOL): Aphakic spectacles (bilateral aphakia) or contact lenses (unilateral aphakia — preferred to reduce aniseikonia)
- Contact lens: Silicone elastomer (Silsoft) in infants; PMMA or RGP in older children
Amblyopia management (critical for visual outcome):
- Patching of the better eye: 1 hour per month of age in unilateral cases (e.g., 6 hours/day at 6 months)
- Regular follow-up with cycloplegic refraction every 3–6 months
- Monitor for and treat glaucoma
Follow-up:
- Lifelong monitoring for glaucoma (annual IOP, disc assessment)
- Frequent refraction and spectacle/CL updates
- Amblyopia therapy until age 7–10 years
Visual outcomes depend critically on:
- Age at surgery: Earlier intervention = better visual prognosis. Unilateral cataracts operated after 10 weeks have significantly worse outcomes.
- Laterality: Bilateral cataracts generally have better final BCVA than unilateral (less amblyopia with symmetric input).
- Density: Dense central cataracts have worse prognosis than partial/lamellar.
- Compliance with amblyopia therapy: Single most important post-operative factor.
Expected outcomes:
- Bilateral cataracts with timely surgery: 60–80% achieve 6/12 or better
- Unilateral cataracts with early surgery + intensive patching: 40–60% achieve 6/12
- IATS: At age 4.5 years, contact lens and IOL groups had similar median visual acuity (~20/159 [logMAR 0.90] for unilateral cataracts operated at median 1.8 months) (Lambert et al. 2014)
- Delayed surgery (>10 weeks unilateral, >10 weeks bilateral): significantly reduced visual potential
Long-term concerns:
- Glaucoma risk persists lifelong (~15–25% cumulative)
- Myopic shift requires frequent refraction
- Secondary procedures (Nd:YAG, secondary IOL, glaucoma surgery) are common
Clinical Pearls
Oral-exam questions
- What is the most common morphological type of congenital cataract? — Lamellar (zonular) cataract. Often autosomal dominant with 'riders' (cortical projections) at the edges (Kanski 9th Ed).
- Name the pathognomonic cataract of galactosemia — Oil-droplet cataract. A central refractile opacity caused by galactitol accumulation. Check urine reducing substances and GALT assay urgently.
- Why is rubella cataract a surgical risk? — The rubella virus may remain viable in the lens for up to 3 years. Surgical specimens are potentially infectious, and the inflammatory response post-operatively can be severe.
- What did the IATS show? — The Infant Aphakia Treatment Study (Lambert et al. 2014) showed no significant difference in visual acuity between primary IOL and contact lens at 4.5 years, but the IOL group had more adverse events and additional surgeries. Contact lens is preferred < 6 months.
- What is the most significant long-term complication after paediatric cataract surgery? — Glaucoma (10–25% cumulative over 10 years). Risk is highest with surgery in the first year of life and in microphthalmic eyes. Requires lifelong monitoring.
- How do you prevent visual axis opacification in children? — Perform primary posterior capsulorhexis + anterior vitrectomy at the time of cataract surgery in children < 5–7 years. Without this, the opacification rate approaches 100%.
- Why is deprivation amblyopia worse than other forms? — During the critical period (first 6–8 weeks of life), the visual cortex requires patterned visual input for normal development. A dense cataract blocking all formed vision causes irreversible failure of cortical synaptic development. This form of amblyopia is more severe and less responsive to treatment than strabismic or anisometropic amblyopia because the cortical neurons never formed proper connections.
Mnemonics
TORCH
Paediatric IOL Undercorrection by Age
GLAUCOMA after Paediatric Cataract
Comparison Tables
| Type | Appearance | Visual Significance | Inheritance / Association | Surgery Needed? |
|---|---|---|---|---|
| Lamellar (zonular) | Zone of opacity with clear cortex; 'riders' | Variable — depends on density | AD (most common hereditary type) | If dense / central |
| Nuclear | Central embryonic/fetal nucleus opacity | Usually significant | AD or sporadic | Usually yes |
| Anterior polar | Small round opacity on anterior capsule | Usually insignificant | Sporadic or AD; persistent pupillary membrane | Rarely |
| Posterior polar | Opacity at posterior pole | Often significant; axial | AD; posterior lenticonus | Yes — but high PCR risk |
| Total | Entire lens opaque (leucocoria) | Severe | Any aetiology | Urgent |
| Oil-droplet | Central refractile opacity | Variable | Pathognomonic of galactosemia | After metabolic control |
| Blue-dot (cerulean) | Scattered blue-white dots | Usually insignificant | AD, non-progressive | No |
- Appearance
- Central embryonic/fetal nucleus opacity
- Visual Significance
- Usually significant
- Inheritance / Association
- AD or sporadic
- Surgery Needed?
- Usually yes
- Appearance
- Small round opacity on anterior capsule
- Visual Significance
- Usually insignificant
- Inheritance / Association
- Sporadic or AD; persistent pupillary membrane
- Surgery Needed?
- Rarely
- Appearance
- Opacity at posterior pole
- Visual Significance
- Often significant; axial
- Inheritance / Association
- AD; posterior lenticonus
- Surgery Needed?
- Yes — but high PCR risk
- Appearance
- Entire lens opaque (leucocoria)
- Visual Significance
- Severe
- Inheritance / Association
- Any aetiology
- Surgery Needed?
- Urgent
- Appearance
- Central refractile opacity
- Visual Significance
- Variable
- Inheritance / Association
- Pathognomonic of galactosemia
- Surgery Needed?
- After metabolic control
- Appearance
- Scattered blue-white dots
- Visual Significance
- Usually insignificant
- Inheritance / Association
- AD, non-progressive
- Surgery Needed?
- No
| Parameter | Primary IOL | Contact Lens (aphakic) |
|---|---|---|
| Median VA at 4.5 years | ~20/159 (logMAR 0.90) | ~20/159 (no significant difference) |
| Adverse events | Higher (VAO, glaucoma, re-operation) | Fewer intraocular complications |
| Additional surgeries | More (for VAO, glaucoma) | Fewer |
| Glaucoma incidence | Higher trend | Lower trend |
| Compliance challenge | None (IOL in situ) | CL insertion/care in infants |
| Current recommendation | Generally avoid IOL < 6 months | Preferred < 6 months per IATS |
- Primary IOL
- ~20/159 (logMAR 0.90)
- Contact Lens (aphakic)
- ~20/159 (no significant difference)
- Primary IOL
- Higher (VAO, glaucoma, re-operation)
- Contact Lens (aphakic)
- Fewer intraocular complications
- Primary IOL
- More (for VAO, glaucoma)
- Contact Lens (aphakic)
- Fewer
- Primary IOL
- Higher trend
- Contact Lens (aphakic)
- Lower trend
- Primary IOL
- None (IOL in situ)
- Contact Lens (aphakic)
- CL insertion/care in infants
- Primary IOL
- Generally avoid IOL < 6 months
- Contact Lens (aphakic)
- Preferred < 6 months per IATS
| Test | Condition Screened | Key Finding |
|---|---|---|
| TORCH titres (IgM/IgG) | Rubella, CMV, Toxoplasma, HSV, syphilis | Elevated IgM = recent infection |
| Urine reducing substances + GALT | Galactosemia | Positive non-glucose reducing substance; low GALT |
| Serum calcium, phosphorus, PTH | Hypoparathyroidism | Low calcium, high phosphorus, low PTH |
| Urine amino acids | Lowe syndrome | Generalised aminoaciduria (renal Fanconi) |
| Karyotype | Trisomy 21, 13, 18; Turner | Abnormal chromosomal complement |
| Blood glucose | Maternal/neonatal diabetes | Hyperglycemia |
- Condition Screened
- Rubella, CMV, Toxoplasma, HSV, syphilis
- Key Finding
- Elevated IgM = recent infection
- Condition Screened
- Galactosemia
- Key Finding
- Positive non-glucose reducing substance; low GALT
- Condition Screened
- Hypoparathyroidism
- Key Finding
- Low calcium, high phosphorus, low PTH
- Condition Screened
- Lowe syndrome
- Key Finding
- Generalised aminoaciduria (renal Fanconi)
- Condition Screened
- Trisomy 21, 13, 18; Turner
- Key Finding
- Abnormal chromosomal complement
- Condition Screened
- Maternal/neonatal diabetes
- Key Finding
- Hyperglycemia
Self-Assessment (5)
A newborn presents with bilateral leucocoria. After ruling out retinoblastoma, slit-lamp shows dense central lens opacities. The parents report no family history of eye disease. What is the most important next step?
A 2-month-old infant is diagnosed with bilateral cataracts and hepatomegaly. Urine reducing substances are positive. What is the most likely metabolic diagnosis?
According to the IATS, which statement is correct regarding management of unilateral congenital cataract in infants?
What is the most feared complication during surgery for posterior polar cataract?
Which morphological type of congenital cataract is the most common overall?
References
- AAO Preferred Practice Pattern: Pediatric Eye Evaluations — Screening and Comprehensive Ophthalmic Evaluation (2022)
- Lambert SR, et al. The Infant Aphakia Treatment Study (IATS): comparison of contact lens and IOL correction of unilateral aphakia at age 4.5 years. JAMA Ophthalmol. 2014;132(6):676-682.
- Taylor D, Hoyt CS. Pediatric Ophthalmology and Strabismus, 6th Edition. Elsevier.
- Kanski JJ, Bowling B. Clinical Ophthalmology: A Systematic Approach, 9th Edition
- AAO Basic and Clinical Science Course (BCSC), Section 6: Pediatric Ophthalmology and Strabismus (2023–2024)
- Rahi JS, Dezateux C. Measuring and interpreting the incidence of congenital ocular anomalies: lessons from a national study of congenital cataract in the UK. Invest Ophthalmol Vis Sci. 2001;42(7):1444-1448.
- Wills Eye Manual, 8th Edition — Pediatric Cataract chapter
Related Content
Topic complete
Continue to another topic when you are ready.